Tandospirone, a 5-HT1A partial agonist is effective in treating anorexia nervosa: a case series

Table 1 Progress in BMI and the EDE-Q of the two cases since administering tandospirone

	Time after tandospirone (weeks)						p value ^a
	Case A			Case B
	0	4	24	0	4	24
BMI	16.4	17.7	18.5	14.9	15.4	16.7	^*p = 0.049
Height	156	156	156	153	153	153
Weight	40.0	43.0	45.0	34.8	36.3	39.0
EDE-Q
Restricting subscale	4.6	3.4	1.2	2.4	2.4	2.4	p = 0.500
Eating concern subscale	1.6	0.6	0.0	4.4	2.2	2.0	p = 0.126
Weight concern subscale	3.6	1.2	2.0	4.2	0.2	0.6	p = 0.234
Shape concern subscale	4.88	4.0	3.0	5.25	1.75	3.5	^*p = 0.023
Global score	3.67	2.3	1.55	4.06	1.64	2.13	^*p = 0.028

^aPaired Student’s t test, two-tailed alpha level of 0.05 at 0 week versus 24 week. ^*p < 0.05.

ISSN: 1744-859X